2015年中国肾脏病网络年度数据报告执行摘要
中国肾脏病网络(CK-NET)于2014年启动,旨在通过整合国家住院患者和医保理赔数据库,生成年度数据报告(ADR)以描述中国肾脏病负担。2015年ADR包含两部分:第一部分基于全国住院患者数据描述CKD住院患者特征;第二部分基于两个全国理赔数据库分析肾脏替代治疗患者,并设有一章基于中国器官移植响应系统分析肾移植等待名单患者。报告发现代谢疾病影响CKD谱、住院患者中CKD和急性肾损伤诊断不足、透析患者并发症治疗欠佳,这些发现将启发后续研究并推动卫生政策改变。
要点
- CK-NET利用全国住院和理赔数据库描述中国CKD及终末期肾病负担。
- 住院患者中CKD和急性肾损伤存在诊断不足。
- 透析患者并发症治疗欠佳,代谢疾病影响CKD谱。
核心结论
- 通过整合国家患者级行政或理赔数据库,可全面描述中国CKD和终末期肾病负担,供多利益相关方使用。
研究设计与样本
- CK-NET于2014年启动,2015年ADR基于多源数据生成,包括全国住院患者数据集、两个全国理赔数据库及中国器官移植响应系统。
主要发现
- 代谢疾病影响CKD谱。
- 住院患者中CKD和急性肾损伤诊断不足。
- 透析患者并发症治疗欠佳。
临床怎么用
- 研究结果可启发后续研究并推动卫生政策改变。
- 数据可用于多利益相关方了解肾脏病负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic kidney disease (CKD) has received increased attention as a leading public health problem worldwide. Globally surveillance systems for kidney disease are still lacking, especially in developing countries like China, which constitutes an obstacle to develop effective preventive strategies. China Kidney Disease Network (CK-NET) was initiated in 2014 and further developed in accordance with the national strategy of prompting Big Data application in China. One major output of CK-NET is to generate an Annual Data Report (ADR) providing resourceful information regarding kidney disease in China. Entering the second cycle of ADR, we have expanded the scope and depth of our research based on the previous ADR. There are 2 sections in the current ADR, generated from data from 2015 from various sources. Section I is based on a dataset of national hospitalized patients and describes the characteristics regarding hospitalized patients with CKD. Section II focuses on patients receiving renal replacement therapy based on 2 nationwide claims databases. There is also a chapter that focuses on patients on the waiting list for renal transplantation based on the China Organ Transplant Response System. Certain findings, including the effect of metabolic disease on the spectrum of CKD, the underdiagnoses of CKD and acute kidney injury among hospitalized patients, and the less-optimal treatment of complications among dialysis patients, will inspire the following research as well as changes in health policy. By integrating and mining national patient-level administrative or claim databases, we are able to provide a comprehensive description of the burden of CKD and end stage kidney disease in China, which could be used by multiple stakeholders with interests in kidney disease.
引用
- Wang F, Yang C, Long J, et al. Executive summary for the 2015 Annual Data Report of the China Kidney Disease Network (CK-NET). Kidney Int. 2019. PMID: 30784660. doi:10.1016/j.kint.2018.11.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。